Abstract:
The present invention relates to a health functional food containing acanthopanaxkoreanumnakai and red ginseng as main ingredients, and to a health functional food which additionally contains xylosma congesta, and in which a form of the food is a soft capsule or a pill form.
Abstract:
The present invention discloses an antioxidative composition using a Xylosma congesta extract. Particularly, the present invention discloses an antioxidative composition with concentration-dependent antioxidation activity using a Xylosma congesta extract in ABTS method, DPPH method, and ORAC method. The antioxiative composition of the present invention is manufactured in foods, cosmetic products, pharmaceutical products, and the like without side effects shown in a synthetic antioxidant using a natural product-derived antioxidative material and is added to prevent rancidity of unsaturated fatty acids contained in products such as foods, cosmetic products, pharmaceutical products, and the like. [Reference numerals] (AA) Xylosma congesta
Abstract:
본 발명은 기능성 입욕제 조성물을 개시한다. 구체적으로 본 발명은 집보리수나무 추출물, 바디나물 추출물, 천선과나무 추출물 등의 약용 식물을 포함하고 또 보리 주박 추출물이나 분말, 송이 분말, 제주도 동부 지역에 부존하는 염지하수의 농축물을 포함함으로서 항스트레스 활성, 피로 회복 활성, 피부 보습 활성 등의 기능성을 가지는 입욕제 조성물을 개시한다.
Abstract:
PURPOSE: A method for isolating collagen from sea cucumber is provided to ensure excellent wound healing effect by treating red sea cucumber with an alkaline solution, centrifuging, and treating with pepsin. CONSTITUTION: A method for isolating collagen from sea cucumber comprises: a step of treating red sea cucumber with an alkaline solution to remove non-collagenous protein; a step of centrifuging and collecting alkaline-treated residue; and a step of treating the residue with an acid solution and pepsin for 24 hours and 72 hours, respectively.
Abstract:
PURPOSE: A composition containing a Sargassum muticum extract or an effective material isolated from the extract for treating allergic diseases is provided to suppress degranulation, cytokine generation, and p-AKT generation. CONSTITUTION: A composition for treating allergic diseases contains 3-beta-hydroxy-5 alpha, and 6 alpha-epoxy-7-megastigmen-9-one as active ingredients. The allergic disease include contact dermatitis, atopic dermatitis, eczema, pruritus, pollenosis, asthma, bronchitis, urticaria, angiitis, rhinitis, gastroenteropathy, diarrhea, arthritis, ophthalmia, conjunctivitis, neuritis, tympanitis, granulomatoses, post-vaccinal encephalomyelitis, cystitis, laryngitis, purpura, food allergy, insect allergy, drug allergy, metal allergy, and anaphylactic shock.
Abstract:
PURPOSE: A composition containing Sargassum muticum extract for relieving allergic diseases is provided to suppress degranulation and cytokine generation. CONSTITUTION: A composition for treating allergic diseases contains Sargassum muticum extract or 3-beta-hydroxy-5 alpha, 6 alpha-epoxy-7-megastigmen-9-one as an active ingredient. The extract is prepared using ethanol, water, or a mixture solvent thereof. The composition is a pharmaceutical, food, or cosmetic composition. A composition for treating inflammatory diseases contains 3-beta-hydroxy-5 alpha, 6 alpha-epoxy-7-megastigmen-9-one as an active ingredient. The daily dose of the pharmaceutical composition is 0.001-150 mg/kg.
Abstract:
PURPOSE: A medium material composition for cultivating mushroom using actinidia chinensis, and a mushroom cultivation method using thereof are provided to use fermented fruits for cultivating the mushroom. CONSTITUTION: A mushroom cultivation method using a medium material composition comprises the following steps: supplying water to the medium material composition to obtain a medium composition having the water content of 40-70wt%; sterilizing the medium sterilizing the medium composition at 100-130 deg C for 60-150 minutes, and cooling; injecting pleurotus ostreatus spawns into the medium composition, and cultivating at 20-25 deg C; and inducing the generation of fruit bodies from the spawns for growing the mushrooms.
Abstract:
PURPOSE: An anti-inflammatory composition and an anti-cancer composition containing Stichopus japonicus is provided to suppress NO generation and inflammatory cytokine generation. CONSTITUTION: A food composition for treating inflammatory diseases contains Stichopus japonicus extract as an active ingredient. The Stichopus japonicus extract is prepared by isolating Stichopus japonicus using a mixture solvent of ethanol and water, removing the solvent, suspending the extract in distilled water, and adding hexane, dichloromethane, ethyl acetate, and butanol.
Abstract:
본발명은꿩꼬리풀추출물을이용한항염증용조성물을개시한다. 구체적으로 LPS(lipopolysaccharide)로자극된대식세포에서 NO 생성억제활성, PGE생성억제활성, 염증성사이토카인(TNF-α, IL-6 및 IL-1β) 생성억제활성그리고 iNOS 및 COX-2 생성억제활성을보이고, LPS로자극된골수유래수지상세포에서염증성사이토카인인 IL-12p40의생성억제활성을보이며, 나아가 IFN-γ로자극된각질형성세포인 HaCaT keratinocytes에서염증성케모카인인 MDC(macrophage-derived chemokine)의생성억제활성을보이는꿩꼬리풀추출물을이용한항염증용조성물을개시한다.